BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15796057)

  • 1. [Amyloidosis in patients undergoing long-term hemodialysis: elucidation of etiological mechanism and therapeutic stratigy].
    Shimojyo F
    Nihon Naika Gakkai Zasshi; 2005 Feb; 94 Suppl():56-60. PubMed ID: 15796057
    [No Abstract]   [Full Text] [Related]  

  • 2. Does dialysis-related amyloidosis regress after transplantation?
    Jadoul M; Drüeke T; Zingraff J; van Ypersele de Strihou C
    Nephrol Dial Transplant; 1997 Apr; 12(4):655-7. PubMed ID: 9140988
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal transplantation relieves the symptoms but does not reverse beta 2-microglobulin amyloidosis.
    Mourad G; Argilés A
    J Am Soc Nephrol; 1996 May; 7(5):798-804. PubMed ID: 8738817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis of dialysis amyloidosis].
    Gejyo F; Hasegawa S; Homma N; Maruyama H; Maruyama S; Arakawa M
    Nihon Rinsho; 1992 Jan; 50 Suppl():796-800. PubMed ID: 1578769
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathophysiology of advanced glycation end-products in renal failure.
    Miyata T; Iida Y; Horie K; Cai Z; Sugiyama S; Maeda K
    Nephrol Dial Transplant; 1996; 11 Suppl 5():27-30. PubMed ID: 9044303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-microglobulin and renal bone disease.
    Wada T; Miyata T; Sakai H; Kurokawa K
    Perit Dial Int; 1999; 19 Suppl 2():S413-6. PubMed ID: 10406556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphology and diagnosis of hemodialysis--related amyloidosis].
    Ohashi K; Kawai R; Hara M
    Nihon Rinsho; 1992 Jan; 50 Suppl():801-6. PubMed ID: 1578770
    [No Abstract]   [Full Text] [Related]  

  • 8. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
    Miyata T; Inagi R; Kurokawa K
    Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does dialysis-associated amyloidosis resolve after transplantation?
    Nelson SR; Sharpstone P; Kingswood JC
    Nephrol Dial Transplant; 1993; 8(4):369-70. PubMed ID: 7685506
    [No Abstract]   [Full Text] [Related]  

  • 10. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
    Miyata T
    Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of beta 2-microglobulin amyloid 10 years after renal transplantation.
    Kessler M; Aymard B; Pourel J
    Nephrol Dial Transplant; 1994; 9(3):333-4. PubMed ID: 8052450
    [No Abstract]   [Full Text] [Related]  

  • 12. [Beta 2-microglobulin-induced amyloidosis. A new complication of long-term hemodialysis].
    Ritz E; Bommer J; Zeier M
    Dtsch Med Wochenschr; 1988 Feb; 113(5):190-6. PubMed ID: 3276494
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction between beta 2-microglobulin and advanced glycation end products in the development of dialysis related-amyloidosis.
    Hou FF; Chertow GM; Kay J; Boyce J; Lazarus JM; Braatz JA; Owen WF
    Kidney Int; 1997 May; 51(5):1514-9. PubMed ID: 9150467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dialysis-related amyloidosis].
    Nakazima Y; Akizawa T; Koshikawa S
    Nihon Rinsho; 1992 Jan; 50 Suppl():807-16. PubMed ID: 1578771
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenesis of amyloidosis: a role for anti-proteases?].
    Argilés i Ciscart A; Mourad G
    Nephrologie; 1991; 12(2):51-4. PubMed ID: 1719439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid, advanced glycation end products, and dialysis related arthropathy.
    McDonald SP; Coates PT; Disney AP
    Ann Rheum Dis; 1998 Apr; 57(4):193-5. PubMed ID: 9709172
    [No Abstract]   [Full Text] [Related]  

  • 17. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A; Gejyo F
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathogenic factors in dialysis-related amyloidosis: current research findings.
    Gejyo F
    Osteoporos Int; 1997; 7 Suppl 3():S197-201. PubMed ID: 9536332
    [No Abstract]   [Full Text] [Related]  

  • 19. Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis.
    Miyata T; Sprague SM
    Nephrol Dial Transplant; 1996; 11 Suppl 3():86-90. PubMed ID: 8840320
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of dialysis-related amyloidosis.
    Miyata T; Maeda K
    Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):493-7. PubMed ID: 8591057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.